Conducting Clinical Trials in a Virtual World
The COVID-19 pandemic has changed our way of life, including the way in which we conduct clinical trials. With patient-centricity a guiding principle, more sponsors are looking to virtual or decentralized hybrid clinical trials to engage those patients who would not have ordinarily made the decision to participate.
This month’s edition of Voyager showcases insights accumulated from conducting a wide-range of virtual clinical trials, along with perspectives on the surprising impact a clinical database has on the success of COVID-19 studies.